Sensodyne

GSK Raises £1.25bn From Offloading Haleon Stake At A Discount

GSK has raised £1.25 billion (€1.46 billion). from selling its entire remaining stake in consumer healthcare firm Haleon, the British drugmaker...

Haleon Posts Tepid Q1 Sales As Demand For Some Products Cool Off

Consumer healthcare company Haleon reported first-quarter revenue slightly below market estimates as volumes declined.

Sensodyne-Maker Haleon To Shut UK Manufacturing Site, With More Than 400 Jobs Hit

Consumer healthcare company Haleon is planning to shut down its manufacturing site in Britain by 2026, which will impact 435 jobs, a spokesperson told Reut...

Top 20 Most Popular Personal Care Brands In Europe

ESM explores the top 20 most popular personal care brands in Europe, as outlined by Kantar's Brand Footprint data for 2022.

GSK Cuts Stake In Haleon To 7.4%, Raises £885.6m

British drugmaker GSK said it raised £885.6 million (€1 billion) from a discounted stake sale in Haleon, cutting its shareholding to 7.4%.

Sensodyne Toothpaste-Maker Haleon Planning Job Cuts - The Guardian

Haleon, the world's biggest standalone consumer health business, is planning to cut hundreds of roles in the UK and potentially thousands worldwide, the Gu...

GSK Sells $1bn Discounted Stake In Spin-Off Haleon

British drugmaker GSK on Friday sold 240 million shares in its consumer healthcare business Haleon at 335 pence per share, raising about £804 million...

Haleon Forecasting 4% To 6% Revenue Growth this Year

Haleon, the world's biggest standalone consumer health business, has forecast 4% to 6% organic revenue growth in 2023.

Consumer Health Firm Haleon Posts 16.1% Jump In Quarterly Sales